The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC): RADIANT trial.
Mary E.R. O'Brien
No relevant relationships to disclose
Wilfried Ernst Erich Eberhardt
Consultant or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Merck Serono; Novartis; Pfizer; Roche; Teva
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Novartis; Pfizer; Roche
Research Funding - Lilly
Nasser K. Altorki
No relevant relationships to disclose
David R. Spigel
No relevant relationships to disclose
Lucio Crino
No relevant relationships to disclose
Chun-Ming Tsai
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche
Eun Kyung Cho
No relevant relationships to disclose
Joo-Hang Kim
Research Funding - Lilly; Pfizer; Roche
Aleksandra Szczesna
No relevant relationships to disclose
Philip C. Hoffman
No relevant relationships to disclose
Otto Burghuber
No relevant relationships to disclose
Shaf Keshavjee
No relevant relationships to disclose
Sergey Orlov
No relevant relationships to disclose
Piotr Serwatowski
No relevant relationships to disclose
Jiuzhou Wang
Employment or Leadership Position - Astellas Pharma
Margaret A. Foley
Employment or Leadership Position - Astellas Pharma
Julie D. Horan
Employment or Leadership Position - Novella Clinical
Jung Wook Park
Employment or Leadership Position - Astellas Pharma
Frances A. Shepherd
Consultant or Advisory Role - Astellas Pharma; OSI Pharmaceuticals; Roche
Honoraria - Roche
Karen Kelly
No relevant relationships to disclose